The efficacy of dexamethasone implants following anti-VEGF failure for macular oedema in retinal vein occlusion.
Timothy E YapSalman HuseinJuan Antonio Miralles de Imperial-OlleroBenedetta ColizziMaria Francesca CordeiroSaad YounisPublished in: European journal of ophthalmology (2020)
DEX implant provides useful rescue therapy in cases of anti-VEGF 'failure' for macular oedema following retinal vein occlusion, resulting in improved functional outcomes at 30 days.